Investor Relation

This section of our website contains essential information on Beximco Pharmaceuticals Ltd. You can view and download our financial reports and keep up to-date with the latest news and company information.

The information on this section is being disclosed for the purposes of AIM Rule 26. Information was last updated on 11th December, 2017.

For latest share prices [LSE: BXP, DSE: BEXPHARMA] click on the following links:

AIM (London Stock Exchange)

Dhaka Stock Exchange

Chittagong Stock Exchange

 

Key Company Information

Key Company Information

 

Year of Establishment: 1976
Country of Incorporation: Bangladesh
Commercial Production: 1980
Status: Public Limited Company.

 Read More

Share Information

Share Information

These however do not include information relating to AIM Securities cleared through Eoroclear that does not disclose holding because of secrecy under the Belgian Law.

 Read More

Financial Reports

Financial Reports

Financial Reports section of our website contains all kinds of soft copy of financial reports and some of them are printed.

 Read More

News & Announcements

News & Announcements

News & Announcements section of our website contains all kinds of soft copy of News & Announcements.

 Read More

Board Details

Board Details

 

Ahmed Sohail Fasiur Rahman, Chairman and
Ahmed Salman Fazlur Rahman,
Vice Chairman

 Read More

Corporate Governance & Committees

Corporate Governance & Committees

 

The Company has a three-tier management structure, comprising the Board of Directors, the Executive Committee and the Management Committee.

 Read More

Adviser

Adviser

Advisers of Beximco Pharma Ltd.

 Read More

Company Documents

Company Documents

 

Beximco Pharmaceuticals Limited placing of 20,000,000 Global Depositary Receipts one ordinary share of taka 10 at a placing of 60 pence per global depository receipt, together with one warrant for ever three GDRs and Admission trading on AIM.

 Read More